Full text is available at the source.
Abstract
A detection limit as low as 10<sup>1</sup> CFU/mL1 CFU/mL** is achieved using a new sensing strategy for single-nucleotide mutations.
- The STAND strategy employs a dual-guide RNA system to enhance the specificity of single-nucleotide mutation discrimination.
- Cis-staggered cleavage of double-stranded DNA generates a sticky-end intermediate that is recognized by a secondary guide RNA.
- This method allows the conversion of single-nucleotide variations into amplified fluorescence signals with high fidelity.
- STAND demonstrates superior accuracy in distinguishing clinically relevant targets compared to conventional qPCR.
- The approach's modular design and minimal guide requirements suggest potential for broader applications in genetic analysis.
Simplified